Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Pablo Oppezzo

6PUBLICATIONS
48CO-AUTHORS
Haematological tumoursInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

Sort by Publication Date:
|Jul 28, 2025
Targeting S100A9-mediated inflammation: a novel therapeutic approach for CLL.

Angimar Uriepero-Palma, Maria Elena Márquez, Eugenia Payque

|Sep 21, 2022
PD-1/PD-L1 blockade abrogates a dysfunctional innate-adaptive immune axis in critical β-coronavirus disease.

Maite Duhalde Vega, Daniela Olivera, Gustavo Gastão Davanzo

|Apr 12, 2022
TGF-β/SMAD Pathway Is Modulated by miR-26b-5p: Another Piece in the Puzzle of Chronic Lymphocytic Leukemia Progression.

Maria Elena Marquez, Sandra Sernbo, Eugenia Payque

|Jul 22, 2021
AID overexpression leads to aggressive murine CLL and nonimmunoglobulin mutations that mirror human neoplasms.

Pablo Elías Morande, Xiao-Jie Yan, Julieta Sepulveda

|Mar 01, 2019
Ibrutinib therapy downregulates AID enzyme and proliferative fractions in chronic lymphocytic leukemia.

Pablo Elías Morande, Mariela Sivina, Angimar Uriepero

|Jun 29, 2018
LPL protein in Chronic Lymphocytic Leukaemia have different origins in Mutated and Unmutated patients. Advances for a new prognostic marker in CLL.

Daniel Prieto, Noé Seija, Angimar Uriepero

Pageof 1

Frequent Collaborators

2 joint publications

Daniel Prieto

2 joint publications

Marcelo Navarrete

2 joint publications

Carolina Oliver

1 joint publications

Pablo Fresia

1 joint publications

Xiao-Jie Yan

1 joint publications

Julieta Sepulveda

1 joint publications

Natalia Sotelo

1 joint publications

Gabriel Fernández-Graña

1 joint publications

Stephen P Methot

1 joint publications

Alejandro Buschiazzo

Frequent Collaborators

2 joint publications

Daniel Prieto

2 joint publications

Marcelo Navarrete

2 joint publications

Carolina Oliver

1 joint publications

Pablo Fresia

Top Related Videos

Expression, Purification, and Antimicrobial Activity of S100A12
11:10

Expression, Purification, and Antimicrobial Activity of S100A12

Published on : May 13, 2017

8.5K
Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on : Feb 05, 2020

5.8K
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on : Oct 27, 2020

13.4K
See more related videos

Top Related Videos

Expression, Purification, and Antimicrobial Activity of S100A12
11:10

Expression, Purification, and Antimicrobial Activity of S100A12

Published on : May 13, 2017

8.5K
Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on : Feb 05, 2020

5.8K
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on : Oct 27, 2020

13.4K
See more related videos